In celebration of #WorldThrombosisDay, VMJ offers free patient info on #VTE, including our first-ever patient page translated to Spanish, by Cassi Frank et al
English: https://t.co/wDhAV9plRF
Spanish: https://t.co/LLdQ7QFb2q
@StephanHDMoll@evratchford#WTDay23
From the current issue: Haraguchi et al. study the association of postprocedural minimum lumen area with clinical outcomes after femoropopliteal drug-eluting stent implantation. https://t.co/RZcDTIj3F7
#PAD#VascularTwitter
Online First! Patient Information Page: Genetic testing for inherited vascular diseases associated with aneurysm and dissection.
An excellent resource for patients and providers by Gretchen MacCarrick & @evratchford.
https://t.co/37yuF8b13H
@MarfanFdn@LDSFoundation@TheEDSociety
Online First! Parkington et al. evaluate the feasibility of a supervised exercise program with blood flow restriction in patients with claudication. Read more about this unique rehabilitation tool and its promising results
https://t.co/BhzlOUoGu3
#PAD#Claudication
From the latest issue: Nondipping blood pressure pattern predicts cardiovascular events in patients with atherosclerotic peripheral vascular disease by Dahle et al.
#Vasculartwitter#PADAwareness
https://t.co/t1NetN00ss
Rethinking albuminuria as a marker to drive 💊in congestive #HF
👉albuminuria is a solid risk marker in HF
💡role especially in HFpEF?
👉albuminuria a risk factor and a target for therapy in HF
📁 https://t.co/Ttvmdosufo